{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:52:26Z","timestamp":1787003546826,"version":"build-2736575974"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/200.939\/2020"],"award-info":[{"award-number":["E-26\/200.939\/2020"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/202.944\/2016"],"award-info":[{"award-number":["E-26\/202.944\/2016"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302069\/2022"],"award-info":[{"award-number":["302069\/2022"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Universal - 433637\/2018\u20138"],"award-info":[{"award-number":["Universal - 433637\/2018\u20138"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto Federal de Educa\u00e7\u00e3o, Ci\u00eancia e Tecnologia do Rio de Janeiro","award":["Pro-Ci\u00eancia\/2019-2022"],"award-info":[{"award-number":["Pro-Ci\u00eancia\/2019-2022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Visceral leishmaniasis (VL) is an infectious disease caused by\n                    <jats:italic>Leishmania infantum<\/jats:italic>\n                    . Clinically, VL evolves with systemic impairment, immunosuppression and hyperactivation with hypergammaglobulinemia. Although renal involvement has been recognized, a dearth of understanding about the underlying mechanisms driving acute kidney injury (AKI) in VL remains. We aimed to evaluate the involvement of immunoglobulins (Igs) and immune complexes (CIC) in the occurrence of AKI in VL patients. Fourteen VL patients were evaluated between early treatment and 12\u00a0months post-treatment (mpt). Anti-\n                    <jats:italic>Leishmania<\/jats:italic>\n                    Igs, CIC, cystatin C, C3a and C5a were assessed and correlated with AKI markers. Interestingly, high levels of CIC were observed in VL patients up to 6\u00a0mpt. Concomitantly, twelve patients met the criteria for AKI, while high levels of cystatin C were observed up to 6\u00a0mpt. Plasmatic cystatin C was positively correlated with CIC and Igs. Moreover, C5a was correlated with cystatin C, CIC and Igs. We did not identify any correlation between amphotericin B use and kidney function markers in VL patients, although this association needs to be further explored in subsequent studies. Our data reinforce the presence of an important renal function impairment during VL, suggesting the involvement of Igs, CIC, and C5a in this\u00a0clinical condition.\n                  <\/jats:p>","DOI":"10.1038\/s41598-024-60209-0","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T22:01:20Z","timestamp":1714428080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A link between circulating immune complexes and acute kidney injury in human visceral leishmaniasis"],"prefix":"10.1038","volume":"14","author":[{"given":"Gabriela","family":"Corr\u00eaa-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luciana","family":"Silva-Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Soares Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rita Teixeira","family":"Dutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermano Gomes","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glaucia","family":"Cota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"de Azevedo Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alda Maria","family":"Da-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Gomes-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna Reis","family":"Santos-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"60209_CR1","unstructured":"World Health Organization. Leishmaniasis. https:\/\/www.who.int\/health-topics\/leishmaniasis#tab=tab_1 (2023)."},{"key":"60209_CR2","unstructured":"Pan American Health Organization. In Leishmaniases Epidemiological Report on the Region of the Americas. https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/56831\/PAHOCDEVT220021_eng.pdf?sequence=1&isAllowed=y (2022)."},{"key":"60209_CR3","doi-asserted-by":"publisher","first-page":"e0009567","DOI":"10.1371\/journal.pntd.0009567","volume":"15","author":"G Cota","year":"2021","unstructured":"Cota, G., Erber, A. C., Schernhammer, E. & Sim\u00f5es, T. C. Inequalities of visceral leishmaniasis case-fatality in Brazil: A multilevel modeling considering space, time, individual and contextual factors. PLoS Negl. Trop. Dis. 15, e0009567 (2021).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"60209_CR4","unstructured":"Minist\u00e9rio da Sa\u00fade (BR). Leishmaniose visceral\u2014casos confirmados notificados no sistema de informa\u00e7\u00e3o de agravos de notifica\u00e7\u00e3o\u2014Minas Gerais. http:\/\/tabnet.datasus.gov.br\/cgi\/tabcgi.exe?sinannet\/cnv\/leishvmg.def (2023)."},{"key":"60209_CR5","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1590\/0037-8682-0258-2016","volume":"49","author":"DL Costa","year":"2016","unstructured":"Costa, D. L. et al. Predicting death from kala-azar: Construction, development, and validation of a score set and accompanying software. Rev. Soc. Bras. Med. Trop. 49, 728\u2013740 (2016).","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"60209_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1590\/S0037-86822003000200004","volume":"36","author":"N Salgado-Filho","year":"2003","unstructured":"Salgado-Filho, N., Ferreira, T. M. A. F. & Costa, J. M. L. Envolvimento da fun\u00e7\u00e3o renal em pacientes com leishmaniose visceral (calazar). Rev. Soc. Bras. Med. Trop. 36, 217\u2013221 (2003).","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"60209_CR7","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1590\/S0037-86822010000400010","volume":"43","author":"CHN Costa","year":"2010","unstructured":"Costa, C. H. N. et al. Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study. Rev. Soc. Bras. Med. Trop. 43, 386\u2013392 (2010).","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"60209_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/INF.0b013e318247f533","volume":"31","author":"AB Lib\u00f3rio","year":"2012","unstructured":"Lib\u00f3rio, A. B. et al. Acute kidney injury in children with visceral leishmaniasis. Pediatr. Infect. Dis. J. 31, 451\u2013454 (2012).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"60209_CR9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza, S., Croft, S. L. & Boelaert, M. Leishmaniasis. The Lancet 392, 951\u2013970 (2018).","journal-title":"The Lancet"},{"key":"60209_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.idc.2018.10.005","volume":"33","author":"J Van Griensven","year":"2019","unstructured":"Van Griensven, J. & Diro, E. Visceral leishmaniasis: Recent advances in diagnostics and treatment regimens. Infect. Dis. Clin. North Am. 33, 79\u201399 (2019).","journal-title":"Infect. Dis. Clin. North Am."},{"key":"60209_CR11","first-page":"245","volume":"123","author":"S Saha","year":"2006","unstructured":"Saha, S. et al. Immune responses in kala-azar. Indian J. Med. Res. 123, 245\u2013266 (2006).","journal-title":"Indian J. Med. Res."},{"key":"60209_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/364534","volume":"2012","author":"JR Santos-Oliveira","year":"2012","unstructured":"Santos-Oliveira, J. R. & Da-Cruz, A. M. Lipopolysaccharide-induced cellular activation may participate in the immunopathogenesis of visceral leishmaniasis alone or in HIV coinfection. Int. J. Microbiol. 2012, 1\u20134 (2012).","journal-title":"Int. J. Microbiol."},{"key":"60209_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06051-5","volume":"21","author":"RC Kuschnir","year":"2021","unstructured":"Kuschnir, R. C. et al. High levels of anti-Leishmania IgG3 and low CD4+ T cells count were associated with relapses in visceral leishmaniasis. BMC Infect. Dis. 21, 1 (2021).","journal-title":"BMC Infect. Dis."},{"key":"60209_CR14","first-page":"58","volume":"56","author":"B Galv\u00e3o-Castro","year":"1984","unstructured":"Galv\u00e3o-Castro, B. et al. Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis. Clin. Exp. Immunol. 56, 58\u201366 (1984).","journal-title":"Clin. Exp. Immunol."},{"key":"60209_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1365-2249.2006.03171.x","volume":"146","author":"V Peruhype-Magalh\u00e3es","year":"2006","unstructured":"Peruhype-Magalh\u00e3es, V. et al. Mixed inflammatory\/regulatory cytokine profile marked by simultaneous raise of interferon-\u03b3 and interleukin-10 and low frequency of tumour necrosis factor-\u03b1+monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection. Clin. Exp. Immunol. 146, 124\u2013132 (2006).","journal-title":"Clin. Exp. Immunol."},{"key":"60209_CR16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1128\/iai.38.3.871-876.1982","volume":"38","author":"A Campos-Neto","year":"1982","unstructured":"Campos-Neto, A. & Bunn-Moreno, M. M. Polyclonal B cell activation in hamsters infected with parasites of the genus Leishmania. Infect. Immun. 38, 871\u2013876 (1982).","journal-title":"Infect. Immun."},{"key":"60209_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0014-4894(82)90095-9","volume":"53","author":"J Weintraub","year":"1982","unstructured":"Weintraub, J., Gottlieb, M. & Weinbaum, F. I. Leishmania tropica: Association of a B-cell mitogen with hypergammaglobulinemia in mice. Exp. Parasitol. 53, 87\u201396 (1982).","journal-title":"Exp. Parasitol."},{"key":"60209_CR18","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","volume":"366","author":"HW Murray","year":"2005","unstructured":"Murray, H. W., Berman, J. D., Davies, C. R. & Saravia, N. G. Advances in leishmaniasis. The Lancet 366, 1561\u20131577 (2005).","journal-title":"The Lancet"},{"key":"60209_CR19","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/1529-0131(199909)42:9<2007::AID-ANR30>3.0.CO;2-X","volume":"42","author":"M Casato","year":"1999","unstructured":"Casato, M. et al. Mixed cryoglobulinemia secondary to visceral Leishmaniasis. Arthritis Rheum. 42, 2007\u20132011 (1999).","journal-title":"Arthritis Rheum."},{"key":"60209_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1128\/mBio.01844-14","volume":"5","author":"LG Gardinassi","year":"2014","unstructured":"Gardinassi, L. G. et al. Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin G Fc N-glycosylation. mBio 5, 6 (2014).","journal-title":"mBio"},{"key":"60209_CR21","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/eji.200939455","volume":"40","author":"E Deak","year":"2010","unstructured":"Deak, E. et al. Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation. Eur. J. Immunol. 40, 1355\u20131368 (2010).","journal-title":"Eur. J. Immunol."},{"key":"60209_CR22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1084\/jem.20041470","volume":"201","author":"SA Miles","year":"2005","unstructured":"Miles, S. A., Conrad, S. M., Alves, R. G., Jeronimo, S. M. B. & Mosser, D. M. A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J. Exp. Med. 201, 747\u2013754 (2005).","journal-title":"J. Exp. Med."},{"key":"60209_CR23","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1128\/iai.56.12.3139-3144.1988","volume":"56","author":"TG Evans","year":"1988","unstructured":"Evans, T. G. & Pearson, R. D. Identification of Leishmania antigens in the sera of patients with American visceral leishmaniasis. Infect. Immun. 56, 3139\u20133144 (1988).","journal-title":"Infect. Immun."},{"key":"60209_CR24","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/infdis\/147.6.1102","volume":"147","author":"RD Pearson","year":"1983","unstructured":"Pearson, R. D. et al. Circulating immune complexes and rheumatoid factors in visceral leishmaniasis. J. Infect. Dis. 147, 1102\u20131102 (1983).","journal-title":"J. Infect. Dis."},{"key":"60209_CR25","first-page":"321","volume":"53","author":"S Datta","year":"2015","unstructured":"Datta, S., Modak, D., Sarkar, S., Saha, B. & Mukhopadhyay, S. Identification and glycobiological characterization of circulating immune complexes in patients with visceral leishmaniasis and post kala azar dermal leishmaniasis. Indian J. Exp. Biol. 53, 321\u2013328 (2015).","journal-title":"Indian J. Exp. Biol."},{"key":"60209_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/00034983.1989.11812356","volume":"83","author":"S Makni","year":"1989","unstructured":"Makni, S., Ayed, K., Ben-Said, M. & Ben-Rachid, M. S. Study of circulating immune complexes during the evolution of visceral Mediterranean leishmaniasis. Ann. Trop. Med. Parasitol. 83, 349\u2013355 (1989).","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"60209_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/00034983.1989.11812381","volume":"83","author":"L Srivastava","year":"1989","unstructured":"Srivastava, L. Detection of antigen specific circulating immune complexes in Indian kala-azar. Ann. Trop. Med. Parasitol. 83, 521\u2013525 (1989).","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"60209_CR28","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/0035-9203(82)90110-9","volume":"76","author":"A Kharazmi","year":"1982","unstructured":"Kharazmi, A., Rezai, H. R., Fani, M. & Behforouz, N. C. Evidence for the presence of circulating immune complexes in serum and C3b and C3d on red cells of kala-azar patients. Trans. R. Soc. Trop. Med. Hyg. 76, 793\u2013796 (1982).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"60209_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fvets.2020.00273","volume":"7","author":"M Gizzarelli","year":"2020","unstructured":"Gizzarelli, M. et al. Assessment of circulating immune complexes during natural and experimental canine leishmaniasis. Front. Vet. Sci. 7, 1\u20137 (2020).","journal-title":"Front. Vet. Sci."},{"key":"60209_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1439-0450.1998.tb00793.x","volume":"45","author":"JM Margarito","year":"1998","unstructured":"Margarito, J. M. et al. Levels of IgM and IgA circulating immune complexes in dogs with leishmaniasis. J. Vet. Med. Ser. B 45, 263\u2013267 (1998).","journal-title":"J. Vet. Med. Ser. B"},{"key":"60209_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1439-0450.1996.tb00342.x","volume":"43","author":"R Lopez","year":"1996","unstructured":"Lopez, R. et al. Circulating immune complexes and renal function in canine leishmaniasis. J. Vet. Med. Ser. B 43, 469\u2013474 (1996).","journal-title":"J. Vet. Med. Ser. B"},{"key":"60209_CR32","first-page":"945","volume":"60","author":"S Sehgal","year":"1982","unstructured":"Sehgal, S., Aikat, B. K. & Pathania, A. G. Immune complexes in Indian kala-azar. Bull. World Health Organ 60, 945\u2013950 (1982).","journal-title":"Bull. World Health Organ"},{"key":"60209_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1023\/A:1026095328695","volume":"253","author":"T Chakraborti","year":"2003","unstructured":"Chakraborti, T., Sarkar, D. & Ghosh, D. K. Immune complex antigens as a tool in serodiagnosis of kala-azar. Mol. Cell Biochem. 253, 191\u2013198 (2003).","journal-title":"Mol. Cell Biochem."},{"key":"60209_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.4269\/ajtmh.1993.49.492","volume":"49","author":"M Quilici","year":"1993","unstructured":"Quilici, M., Lamouroux, D., Mary, C., Dunan, S. & Ange, G. Characterization of a circulating antigen involved in immune complexes in visceral leishmaniasis patients. Am. J. Trop. Med. Hyg. 49, 492\u2013501 (1993).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"60209_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1134\/S0006297909050010","volume":"74","author":"KV Shmagel","year":"2009","unstructured":"Shmagel, K. V. & Chereshnev, V. A. Molecular bases of immune complex pathology. Biochem. (Moscow) 74, 469\u2013479 (2009).","journal-title":"Biochem. (Moscow)"},{"key":"60209_CR36","first-page":"234","volume":"30","author":"CM Marzocchi-Machado","year":"1997","unstructured":"Marzocchi-Machado, C. M. & Lucisano-Valim, Y. M. Clearance de imunocomplexos: Papel do complemento e dos polimorfonucleares neutr\u00f3filos. Med. Ribeirao Preto 30, 234 (1997).","journal-title":"Med. Ribeirao Preto"},{"key":"60209_CR37","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/ki.1989.83","volume":"35","author":"JA Schifferli","year":"1989","unstructured":"Schifferli, J. A. & Taylor, R. P. Physiological and pathological aspects of circulating immune complexes. Kidney Int. 35, 993\u20131003 (1989).","journal-title":"Kidney Int."},{"key":"60209_CR38","doi-asserted-by":"publisher","first-page":"107970","DOI":"10.1016\/j.exppara.2020.107970","volume":"218","author":"CM Campelo","year":"2020","unstructured":"Campelo, C. M. et al. Modulation in the expression of type 1 (CR1\/CD35) and type 3 (CR3\/CD11b) complement receptors on leukocytes from patients with Visceral leishmaniasis. Exp. Parasitol. 218, 107970 (2020).","journal-title":"Exp. Parasitol."},{"key":"60209_CR39","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1159\/000186348","volume":"57","author":"A Poli","year":"1991","unstructured":"Poli, A. et al. Renal involvement in canine leishmaniasis. Nephron 57, 444\u2013452 (1991).","journal-title":"Nephron"},{"key":"60209_CR40","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/j.1699-0463.1989.tb00529.x","volume":"97","author":"N Marcussen","year":"1989","unstructured":"Marcussen, N., Vetner, M. & Kristensen, H. M. Interstitial nephritis and glomerulonephritis in visceral leishmaniasis in a dog. APMIS 97, 1137\u20131140 (1989).","journal-title":"APMIS"},{"key":"60209_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1590\/S0036-46652013000200008","volume":"55","author":"RS Rigo","year":"2013","unstructured":"Rigo, R. S. et al. Renal histopathological findings in dogs with visceral leishmaniasis. Rev. Inst. Med. Trop. Sao Paulo 55, 113\u2013116 (2013).","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"60209_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1590\/S0036-46651989000300002","volume":"31","author":"WL Tafuri","year":"1989","unstructured":"Tafuri, W. L. et al. Estudo, ao microsc\u00f3pio \u00f3ptico e eletr\u00f4nico, do rim de caes natural e experimentalmente infectados com Leishmania (Leishmania) chagasi. Rev. Inst. Med. Trop. Sao Paulo 31, 139\u2013145 (1989).","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"60209_CR43","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1354\/vp.40-6-677","volume":"40","author":"FAL Costa","year":"2003","unstructured":"Costa, F. A. L. et al. Histopathologic patterns of nephropathy in naturally acquired canine Visceral leishmaniasis. Vet. Pathol. 40, 677\u2013684 (2003).","journal-title":"Vet. Pathol."},{"key":"60209_CR44","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1007\/s00436-018-6032-2","volume":"117","author":"FO Frazilio","year":"2018","unstructured":"Frazilio, F. O. et al. Biomarkers and renal arterial resistive index in dogs naturally infected with Leishmania infantum. Parasitol. Res. 117, 3399\u20133405 (2018).","journal-title":"Parasitol. Res."},{"key":"60209_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0304-4017(92)90025-5","volume":"45","author":"CG Nieto","year":"1992","unstructured":"Nieto, C. G., Navarrete, I., Habela, M. A., Serrano, F. & Redondo, E. Pathological changes in kidneys of dogs with natural Leishmania infection. Vet. Parasitol. 45, 33\u201347 (1992).","journal-title":"Vet. Parasitol."},{"key":"60209_CR46","first-page":"256","volume":"120","author":"AV Oliveira","year":"1985","unstructured":"Oliveira, A. V., Roque-Barreira, M. C., Sartori, A., Campos-Neto, A. & Rossi, M. A. Mesangial proliferative glomerulonephritis associated with progressive amyloid deposition in hamsters experimentally infected with Leishmania donovani. Am. J. Pathol. 120, 256\u2013262 (1985).","journal-title":"Am. J. Pathol."},{"key":"60209_CR47","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1590\/S0100-879X2007000600011","volume":"40","author":"MG Prianti","year":"2007","unstructured":"Prianti, M. G., Yokoo, M., Saldanha, L. C. B., Costa, F. A. L. & Goto, H. Leishmania (Leishmania) chagasi-infected mice as a model for the study of glomerular lesions in visceral leishmaniasis. Braz. J. Med. Biol. Res. 40, 819\u2013823 (2007).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"60209_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0272-6386(85)80034-2","volume":"6","author":"M Dutra","year":"1985","unstructured":"Dutra, M. et al. Renal Involvement in Visceral Leishmaniasis. Am. J. Kidney Dis. 6, 22\u201327 (1985).","journal-title":"Am. J. Kidney Dis."},{"key":"60209_CR49","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000168337","volume":"11","author":"F Caravaca","year":"1991","unstructured":"Caravaca, F., Mu\u00f1oz, A., Pizarro, J. L., de Santamaria, J. S. & Fernandez-Alonso, J. Acute renal failure in visceral leishmaniasis. Am. J. Nephrol. 11, 350\u2013352 (1991).","journal-title":"Am. J. Nephrol."},{"key":"60209_CR50","doi-asserted-by":"publisher","first-page":"e0252419","DOI":"10.1371\/journal.pone.0252419","volume":"16","author":"W Hailu","year":"2021","unstructured":"Hailu, W. et al. Acute kidney injury in patients with visceral leishmaniasis in Northwest Ethiopia. PLoS One 16, e0252419 (2021).","journal-title":"PLoS One"},{"key":"60209_CR51","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.4049\/jimmunol.178.8.5383","volume":"178","author":"AI Elshafie","year":"2007","unstructured":"Elshafie, A. I., \u00c5hlin, E., Mathsson, L., ElGhazali, G. & R\u00f6nnelid, J. Circulating immune complexes (IC) and IC-induced levels of GM-CSF are increased in sudanese patients with acute visceral Leishmania donovani infection undergoing sodium stibogluconate treatment: Implications for disease pathogenesis. J. Immunol. 178, 5383\u20135389 (2007).","journal-title":"J. Immunol."},{"key":"60209_CR52","doi-asserted-by":"publisher","first-page":"935","DOI":"10.5858\/2004-128-935-LITG","volume":"128","author":"PV Kumar","year":"2004","unstructured":"Kumar, P. V., Daneshbod, Y. & Sadeghipoor, A. Leishmania in the glomerulus. Arch. Pathol. Lab. Med. 128, 935\u2013936 (2004).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"60209_CR53","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0035-9203(83)90131-1","volume":"77","author":"MIS Duarte","year":"1983","unstructured":"Duarte, M. I. S., Silva, M. R. R., Goto, H., Nicodemo, E. L. & Neto, V. A. Interstitial nephritis in human kala-azar. Trans. R. Soc. Trop. Med. Hyg. 77, 531\u2013537 (1983).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"60209_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1590\/S1413-86702008000400015","volume":"12","author":"EF Daher","year":"2008","unstructured":"Daher, E. F. et al. Clinical presentation and renal evaluation of human visceral leishmaniasis (kala-azar): A retrospective study of 57 patients in Brazil. Braz. J. Infect. Dis. 12, 4 (2008).","journal-title":"Braz. J. Infect. Dis."},{"key":"60209_CR55","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/tmi.13127","volume":"23","author":"GC Meneses","year":"2018","unstructured":"Meneses, G. C. et al. Visceral leishmaniasis-associated nephropathy in hospitalised Brazilian patients: New insights based on kidney injury biomarkers. Trop. Med. Int. Health 23, 1046\u20131057 (2018).","journal-title":"Trop. Med. Int. Health"},{"key":"60209_CR56","doi-asserted-by":"publisher","first-page":"492","DOI":"10.5414\/CNP71492","volume":"71","author":"FAAL Verde","year":"2009","unstructured":"Verde, F. A. A. L. et al. Renal tubular dysfunction in human visceral leishmaniasis (Kala-azar). Clin. Nephrol. 71, 492\u2013500 (2009).","journal-title":"Clin. Nephrol."},{"key":"60209_CR57","first-page":"2083","volume":"9","author":"EM Melo","year":"2017","unstructured":"Melo, E. M. et al. Fatores Preditivos de Les\u00e3o Renal Aguda em Pacientes Internados em unidade de terapia intensiva. Rev. Tend\u00ean. Enferm. Profis. 9, 2083\u20132088 (2017).","journal-title":"Rev. Tend\u00ean. Enferm. Profis."},{"key":"60209_CR58","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.amsu.2022.103821","volume":"78","author":"AH Mohamed","year":"2022","unstructured":"Mohamed, A. H. & Bashir, A. M. Acute kidney injury as initial presentation of visceral leishmaniasis in a young patient- A case report. Ann. Med. Surg. 78, 1456 (2022).","journal-title":"Ann. Med. Surg."},{"key":"60209_CR59","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4269\/ajtmh.2010.09-0571","volume":"82","author":"M Oliveira","year":"2010","unstructured":"Oliveira, M. et al. Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar). Am. J. Trop. Med. Hyg. 82, 449\u2013453 (2010).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"60209_CR60","doi-asserted-by":"publisher","first-page":"864","DOI":"10.4269\/ajtmh.2006.75.864","volume":"75","author":"AI ElShafie","year":"2006","unstructured":"ElShafie, A. I., Elghazali, G., R\u00f6nnelid, J. & Venge, P. Cystatin C as a marker of immune complex-associated renal impairment in a Sudanese population with visceral leishmaniasis. Am. J. Trop. Med. Hyg. 75, 864\u2013868 (2006).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"60209_CR61","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1159\/000188621","volume":"70","author":"K Jung","year":"1995","unstructured":"Jung, K. & Jung, M. Cystatin C: A promising marker of glomerular filtration rate to replace creatinine. Nephron 70, 370\u2013371 (1995).","journal-title":"Nephron"},{"key":"60209_CR62","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/00365519609088795","volume":"56","author":"O Tenstad","year":"1996","unstructured":"Tenstad, O., Roald, A. B., Grubb, A. & Aukland, K. Renal handling of radiolabelled human cystatin C in the rat. Scand. J. Clin. Lab. Invest. 56, 409\u2013414 (1996).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"60209_CR63","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1523-1755.2004.00861.x","volume":"66","author":"S Herget-Rosenthal","year":"2004","unstructured":"Herget-Rosenthal, S. et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 66, 1115\u20131122 (2004).","journal-title":"Kidney Int."},{"key":"60209_CR64","first-page":"430","volume":"20","author":"FAA Lima-Verde","year":"2007","unstructured":"Lima-Verde, F. A. A. et al. Evaluation of renal function in human visceral leishmaniasis (kala-azar): A prospective study on 50 patients from Brazil. J. Nephrol. 20, 430\u2013436 (2007).","journal-title":"J. Nephrol."},{"key":"60209_CR65","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1590\/S1413-86702006000200005","volume":"10","author":"RH Berdichevski","year":"2006","unstructured":"Berdichevski, R. H., Luis, L. B., Crestana, L. & Manfro, R. C. Amphotericin B-related nephrotoxicity in low-risk patients. Braz. J. Infect. Dis. 10, 2 (2006).","journal-title":"Braz. J. Infect. Dis."},{"key":"60209_CR66","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/0140-6736(91)91708-3","volume":"337","author":"RN Davidson","year":"1991","unstructured":"Davidson, R. N., Scott, A., Maini, M., Bryceson, A. D. M. & Croft, S. L. Liposomal amphotericin B in drug-resistant visceral leishmaniasis. The Lancet 337, 1061\u20131062 (1991).","journal-title":"The Lancet"},{"key":"60209_CR67","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/myc.12283","volume":"58","author":"DR Falci","year":"2015","unstructured":"Falci, D. R., da Rosa, F. B. & Pasqualotto, A. C. Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: A real-life study. Mycoses 58, 104\u2013112 (2015).","journal-title":"Mycoses"},{"key":"60209_CR68","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1086\/380971","volume":"38","author":"S Sundar","year":"2004","unstructured":"Sundar, S. et al. Amphotericin B treatment for indian visceral leishmaniasis: Conventional versus lipid formulations. Clin. Infect. Dis. 38, 377\u2013383 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"60209_CR69","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1056\/NEJM199903113401004","volume":"340","author":"TJ Walsh","year":"1999","unstructured":"Walsh, T. J. et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. New Engl. J. Med. 340, 764\u2013771 (1999).","journal-title":"New Engl. J. Med."},{"key":"60209_CR70","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jiac.2018.04.014","volume":"24","author":"H Kato","year":"2018","unstructured":"Kato, H. et al. The evaluation of frequency of nephrotoxicity caused by liposomal amphotericin B. J. Infect. Chemotherapy 24, 725\u2013728 (2018).","journal-title":"J. Infect. Chemotherapy"},{"key":"60209_CR71","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1198-743X.2004.00963.x","volume":"10","author":"J-M Aguado","year":"2004","unstructured":"Aguado, J.-M., Lumbreras, C. & Gonz\u00e1lez-Vidal, D. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: A pharmacosurveillance study in Spain. Clin. Microbiol. Infect. 10, 785\u2013790 (2004).","journal-title":"Clin. Microbiol. Infect."},{"key":"60209_CR72","first-page":"206","volume":"25","author":"F Alvarez-Lerma","year":"2012","unstructured":"Alvarez-Lerma, F. et al. Impact of liposomal amphotericin B on renal function in critically ill patients with renal function impairment. Rev. Esp. Quimioter. 25, 206\u2013215 (2012).","journal-title":"Rev. Esp. Quimioter."},{"key":"60209_CR73","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4269\/ajtmh.21-0978","volume":"106","author":"GF Bezerra","year":"2022","unstructured":"Bezerra, G. F. et al. Preliminary study for new markers of early tubuloglomerular injury and renal inflammation in patients with visceral leishmaniasis receiving liposomal amphotericin B treatment. Am. J. Trop. Med. Hyg. 106, 1191\u20131195 (2022).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"60209_CR74","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.4269\/ajtmh.2011.11-0449","volume":"85","author":"D Zhang","year":"2011","unstructured":"Zhang, D., Li, L., Zhao, S. & Mao, Q. Acute renal injury as a result of liposomal amphotericin B treatment in sodium stibogluconate unresponsive visceral leishmaniasis. Am. J. Trop. Med. Hyg. 85, 1035\u20131037 (2011).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"60209_CR75","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0165-2427(95)05434-8","volume":"48","author":"A Mart\u00ednez-Moreno","year":"1995","unstructured":"Mart\u00ednez-Moreno, A., Moreno, T., Mart\u00ednez-Moreno, F. J., Acosta, I. & Hern\u00e1ndez, S. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis. Vet. Immunol. Immunopathol. 48, 209\u2013220 (1995).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"60209_CR76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4269\/ajtmh.1975.24.9","volume":"24","author":"T De-Brito","year":"1975","unstructured":"De-Brito, T., Hoshino-Shimizu, S., Neto, V. A., Duarte, I. S. & Penna, D. O. Glomerular involvement in human kala-azar. A light, immunofluorescent, and electron microscopic study based on kidney biopsies. Am. J. Trop. Med. Hyg. 24, 9\u201318 (1975).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"60209_CR77","doi-asserted-by":"publisher","unstructured":"Onopiuk, A., Tokarzewicz, A. & Gorodkiewicz, E. Chapter Two\u2014Cystatin C: A Kidney Function Biomarker 57\u201369 (Springer, 2015). https:\/\/doi.org\/10.1016\/bs.acc.2014.11.007.","DOI":"10.1016\/bs.acc.2014.11.007"},{"key":"60209_CR78","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/MNH.0000000000000115","volume":"24","author":"TW Ferguson","year":"2015","unstructured":"Ferguson, T. W., Komenda, P. & Tangri, N. Cystatin C as a biomarker for estimating glomerular filtration rate. Curr. Opin. Nephrol. Hypertens. 24, 295\u2013300 (2015).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"60209_CR79","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/ki.2010.431","volume":"79","author":"N Tangri","year":"2011","unstructured":"Tangri, N. et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int. 79, 471\u2013477 (2011).","journal-title":"Kidney Int."},{"key":"60209_CR80","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1258\/0004563001901524","volume":"37","author":"H Finney","year":"2000","unstructured":"Finney, H., Newman, D. J. & Price, C. P. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann. Clin. Biochem. Int. J. Lab. Med. 37, 49\u201359 (2000).","journal-title":"Ann. Clin. Biochem. Int. J. Lab. Med."},{"key":"60209_CR81","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/01.mnh.0000247505.71915.05","volume":"15","author":"M Madero","year":"2006","unstructured":"Madero, M., Sarnak, M. J. & Stevens, L. A. Serum cystatin C as a marker of glomerular filtration rate. Curr. Opin. Nephrol. Hypertens. 15, 610\u2013616 (2006).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"60209_CR82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5005\/japi-11001-0110","volume":"70","author":"VK Pandey","year":"2022","unstructured":"Pandey, V. K., Mani-Mazumdar, P., Vidyapati, G. & Prasad, M. L. Study of serum cystatin C and serum creatinine in different stages of chronic kidney disease patients. J. Assoc. Physicians India 70, 11\u201312 (2022).","journal-title":"J. Assoc. Physicians India"},{"key":"60209_CR83","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s10157-010-0334-8","volume":"14","author":"T Okura","year":"2010","unstructured":"Okura, T. et al. Association between cystatin C and inflammation in patients with essential hypertension. Clin. Exp. Nephrol. 14, 584\u2013588 (2010).","journal-title":"Clin. Exp. Nephrol."},{"key":"60209_CR84","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0961203311425527","volume":"21","author":"R Lertnawapan","year":"2012","unstructured":"Lertnawapan, R. et al. Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus. Lupus 21, 279\u2013287 (2012).","journal-title":"Lupus"},{"key":"60209_CR85","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/INF.0000000000000960","volume":"35","author":"\u00c0 Dey\u00e0-Mart\u00ednez","year":"2016","unstructured":"Dey\u00e0-Mart\u00ednez, \u00c0. et al. Cystatin C: A marker for inflammation and renal function among HIV-infected children and adolescents. Pediatr. Infect. Dis. J. 35, 196\u2013200 (2016).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"60209_CR86","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40620-021-01139-2","volume":"35","author":"A Zinellu","year":"2022","unstructured":"Zinellu, A. & Mangoni, A. A. Cystatin C, COVID-19 severity and mortality: A systematic review and meta-analysis. J. Nephrol. 35, 59\u201368 (2022).","journal-title":"J. Nephrol."},{"key":"60209_CR87","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/00365513.2010.546879","volume":"71","author":"A Grubb","year":"2011","unstructured":"Grubb, A. et al. Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation. Scand. J. Clin. Lab. Invest. 71, 145\u2013149 (2011).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"60209_CR88","unstructured":"Norina, U. & Pavan, A. Type III Hypersensitivity Reaction. StatPearls [Internet] https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559122\/# (2023)."},{"key":"60209_CR89","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1681\/ASN.2011030304","volume":"23","author":"WG Couser","year":"2012","unstructured":"Couser, W. G. Basic and translational concepts of immune-mediated glomerular diseases. J. Am. Soc. Nephrol. 23, 381\u2013399 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"60209_CR90","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/ki.2014.49","volume":"86","author":"WG Couser","year":"2014","unstructured":"Couser, W. G. & Johnson, R. J. The etiology of glomerulonephritis: Roles of infection and autoimmunity. Kidney Int. 86, 905\u2013914 (2014).","journal-title":"Kidney Int."},{"key":"60209_CR91","doi-asserted-by":"publisher","first-page":"e00271","DOI":"10.1016\/j.plabm.2022.e00271","volume":"30","author":"AC Tran","year":"2022","unstructured":"Tran, A. C. et al. Urine testing to differentiate glomerular from tubulointerstitial diseases on kidney biopsy. Pract. Lab. Med. 30, e00271 (2022).","journal-title":"Pract. Lab. Med."},{"key":"60209_CR92","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1053\/j.ajkd.2015.02.342","volume":"66","author":"MA Perazella","year":"2015","unstructured":"Perazella, M. A. The urine sediment as a biomarker of kidney disease. Am. J. Kidney Dis. 66, 748\u2013755 (2015).","journal-title":"Am. J. Kidney Dis."},{"key":"60209_CR93","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.kint.2016.11.018","volume":"91","author":"AL Williams","year":"2017","unstructured":"Williams, A. L. et al. C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy. Kidney Int. 91, 1386\u20131397 (2017).","journal-title":"Kidney Int."},{"key":"60209_CR94","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1681\/ASN.2011111072","volume":"23","author":"Q Peng","year":"2012","unstructured":"Peng, Q. et al. C3a and C5a promote renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 23, 1474\u20131485 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"60209_CR95","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s11255-018-1844-7","volume":"50","author":"M Tang","year":"2018","unstructured":"Tang, M. et al. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a\/C5aR pathway activation. Int. Urol. Nephrol. 50, 1545\u20131553 (2018).","journal-title":"Int. Urol. Nephrol."},{"key":"60209_CR96","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1002\/eji.200526327","volume":"35","author":"L Bao","year":"2005","unstructured":"Bao, L. et al. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur. J. Immunol. 35, 2496\u20132506 (2005).","journal-title":"Eur. J. Immunol."},{"key":"60209_CR97","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/cei.12961","volume":"189","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Targeting C3a\/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice. Clin. Exp. Immunol. 189, 60\u201370 (2017).","journal-title":"Clin. Exp. Immunol."},{"key":"60209_CR98","doi-asserted-by":"publisher","first-page":"e0192361","DOI":"10.1371\/journal.pone.0192361","volume":"13","author":"X Huang","year":"2018","unstructured":"Huang, X. et al. The role of complement activation in rhabdomyolysis-induced acute kidney injury. PLoS One 13, e0192361 (2018).","journal-title":"PLoS One"},{"key":"60209_CR99","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2337\/db19-0043","volume":"69","author":"SM Tan","year":"2020","unstructured":"Tan, S. M. et al. Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agility. Diabetes 69, 83\u201398 (2020).","journal-title":"Diabetes"},{"key":"60209_CR100","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1523-1755.2001.00780.x","volume":"60","author":"K Abe","year":"2001","unstructured":"Abe, K. et al. Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization. Kidney Int. 60, 137\u2013146 (2001).","journal-title":"Kidney Int."},{"key":"60209_CR101","doi-asserted-by":"publisher","first-page":"856","DOI":"10.2215\/CJN.08110910","volume":"6","author":"BS Moffett","year":"2011","unstructured":"Moffett, B. S. & Goldstein, S. L. Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin. J. Am. Soc. Nephrol. 6, 856\u2013863 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"60209_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0182474","volume":"12","author":"F Jamal","year":"2017","unstructured":"Jamal, F. et al. Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis. PLoS One 12, 1\u201322 (2017).","journal-title":"PLoS One"},{"key":"60209_CR103","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/kisup.2012.7","volume":"2","author":"C Wanner","year":"2012","unstructured":"Wanner, C. & Tonelli, M. Summary of recommendation statements. Kidney Int. Suppl. 2, 8\u201312 (2012).","journal-title":"Kidney Int. Suppl."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60209-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60209-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60209-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T23:50:00Z","timestamp":1714434600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60209-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["60209"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-60209-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3286227\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"assertion":[{"value":"22 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9870"}}